Market Place
Sourcing Support
Gemina Laboratories Ltd. Announces Delisting From The CSE
25 Mar 2026 //
PHARMIWEB
Gemina Laboratories Announces Termination Of Transaction
01 Oct 2025 //
PHARMAWEB
Gemina Laboratories Announces Private Placement
13 Nov 2024 //
ACCESSWIRE
Gemina Laboratories Strategic Update
10 Jul 2024 //
ACCESSWIRE
Gemina Laboratories Commences Trading on the OTCQB Market in the United States
20 Jun 2024 //
ACCESSWIRE
Gemina Labs Announces Addition to its IP Portfolio
09 Apr 2024 //
ACCESSWIRE
Gemina Laboratories Sign First Strategic License Agreement
02 Apr 2024 //
ACCESSWIRE
Gemina Labs Update Focusing on Respiratory Infections and Strategic Partnerships
21 Mar 2024 //
ACCESSWIRE
Gemina Announces Closing of $910,000 Convertible Note Financing
19 Mar 2024 //
ACCESSWIRE
Gemina Labs Ltd Appoints Stifel as Financial Advisor
06 Nov 2023 //
ACCESSWIRE
Gemina Announces Breakthrough in Environmentally Friendly Lateral Flow Test Design
25 Jul 2023 //
ACCESSWIRE
Gemina Chemistry Platform Demonstrate Lateral Flow Assay Performance Improvement
17 May 2023 //
ACCESSWIRE
Readygo, Gemina Labs ink assay development agreement for rapid detection
20 Apr 2023 //
PHARMABIZ
Gemina Labs Appoints Diagnostic Strategist Martha Najib to the Board
07 Mar 2023 //
ACCESSWIRE
Gemina Announces Appointment of Leader Dr. Bola Grace to The Board of Directors
26 Jan 2023 //
ACCESSWIRE
Gemina Labs Appoints Dr. Stefan Hamill as Vice President, Strategy
23 Jan 2023 //
ACCESSWIRE
Gemina Labs Appoints Dr Michael Shannon as Chair of Clinical Advisory Board
20 Dec 2022 //
ACCESSWIRE
Gemina`s Recent Investment into RAPIvD Sees Immediate Progress
13 Dec 2022 //
ACCESSWIRE
Gemina Labs Announces Strategic Stake in British Rapid Test Optimizer Rapivd Ltd
07 Dec 2022 //
ACCESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.